Quincy was just 4 months old when he was diagnosed with juvenile myelomonocytic leukemia (JMML), a rare type of leukemia that comes with a poor prognosis. First attempts at getting Quincy to reach remission and be well enough for a bone marrow transplant failed. He kept getting sicker and sicker. Because of an ALSF Center of Excellence Grant, Quincy’s doctors at the University of California San Francisco had access to an advanced genetic test. That test revealed that Quincy had a rare mutation, and that mutation had a matching drug to treat it: a therapy previously approved for use in adult liver and kidney cancers.

The drug worked.

Quincy is now 8 years old. Every milestone in his young life — from first steps to first words to first days of school — has been because of a treatment that saved his life. Read more about Quincy and other childhood cancer survivors on The Childhood Cancer Blog linked in bio! #cancersurvivorsmonth #childhoodcancer